サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ケタミン療法クリニック市場：治療別、療法別、紹介元別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1320173

ケタミン療法クリニック市場：治療別、療法別、紹介元別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Ketamine Clinics Market with COVID-19 Impact Analysis, By Treatment, By Therapy, By Referral Source, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 333 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
ケタミン療法クリニック市場：治療別、療法別、紹介元別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 333 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ケタミン療法クリニックの市場規模は2022年に87億450万米ドルとなり、2023年から2030年にかけてCAGR 11.3％で拡大

ケタミン療法クリニック市場-市場力学：

調査・臨床試験とケタミン需要の増加が市場成長を後押し

精神疾患の有病率の増加と従来の治療法の限界とが相まって、ケタミンなどの代替療法に対する需要が高まっています。さらに、初期の研究では肯定的な結果が得られているため、精神衛生上の懸念の治療に対するケタミンの長期的な安全性と有効性を判断するためには、より多くの臨床試験と調査が必要です。さらに、研究が進展するにつれて、治療の選択肢としてのケタミンに対する見方や受け入れられ方が変化する可能性もあります。さらに、ケタミン療法が認知されるにつれ、既存の診療所や精神科クリニックの中には、ケタミン療法を製品ラインナップの一部に加え始めたところもあります。しかし、ケタミン療法に対する保険適用が大きな課題となる可能性があり、これが予測期間におけるケタミン療法クリニックの市場成長を抑制する可能性があります。

ケタミン療法クリニック市場-主要インサイト：

  • ケタミン療法クリニック産業は、メンタルヘルス状態の有病率の上昇と従来の治療法の限界により、著しい速度で成長すると予測される
  • 治療セグメンテーションに基づくと、オンサイト療法が近い将来に最大の市場シェアを示すと予測される
  • 治療セグメンテーションに基づくと、うつ病が2022年の主要タイプ
  • 地域別では、北米が2022年の主要な収益源

ケタミン療法クリニック市場-セグメンテーション分析：

世界のケタミン療法クリニック市場は、治療、照会ソース、地域に基づいてセグメント化されます。

市場は治療に基づいて3つのカテゴリーに分けられる：不安、うつ病、PTSD、その他。うつ病分野は、重度の大うつ病を患う成人が増加していることから、最大の売上シェアを占めると思われます。また、医学界では、ケタミンはうつ病の治療に使用される可能性があるとして注目を集めています。さらに、ケタミン療法クリニックは、うつ病やその他の気分障害に苦しむ患者にケタミン療法を提供する専門センターとして出現しています。

市場は、オンライン療法とオンサイト療法の2つに分類されます。予測期間中、市場シェアを占めるのはオンサイト療法です。精神疾患の場合、ケタミン療法の受け入れ拡大がケタミンの拡大につながり、さらに同セグメントの成長を牽引しています。さらに、カウンセラー、心理学者、精神科医など、精神衛生の専門家も患者に治療セッションを提供しています。

市場は、プライマリケア医、オンライン広告、メンタルヘルス専門家という紹介元に基づく3つのカテゴリーに分けられます。プライマリケア医セグメントは市場シェアを独占すると予想されます。PCPは、不安障害やうつ病のようなメンタルヘルス障害のような数多くの病状を診断・治療するのに適しています。さらに、プライマリケア医が、ケタミン療法が重度または治療抵抗性のうつ病やその他の精神衛生上の懸念に役立つかもしれないと考える場合、さらに、プライマリケア医は、ケタミン療法が重度のうつ病または治療抵抗性のうつ病やその他の精神的健康上の懸念に役立つ可能性があると考える場合、患者をケタミン療法クリニックに送ることがあります。このような要因によって、同セグメントの成長が促進される可能性があります。

ケタミン療法クリニック市場-地理的洞察：

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国ごとにさらに分割されます。

ケタミン臨床市場-競合情勢：

市場は、進行中のオピオイド危機、メンタルヘルス意識の高まり、世界中のケタミン療法クリニックの数の多さなどの要因によって、著しい成長を示しています。さらに、ケタミン療法クリニック業界は、市場でのプレゼンスを世界的に拡大するために、提携、新サービスの開始、M&A、事業拡大など数多くの戦略に注力しています。さらに、より多くのプロバイダーがこの分野に参入しているため、ケタミン療法クリニック市場の競争は激化しています。例えば、2023年4月、MindbloomはSHIFTとの提携を発表し、従業員への福利厚生として在宅ケタミン療法を提供することになっています。さらに、この提携により、SHIFTの全従業員は、Mindbloomを通じて、通常の数分の一の価格で在宅ケタミン療法を利用できるようになります。

目次

第1章 ケタミン療法クリニック市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ケタミン療法クリニックの主要な市場動向

  • ケタミン療法クリニック市場促進要因
  • ケタミン療法クリニック市場抑制要因
  • ケタミン療法クリニック市場機会
  • ケタミン療法クリニック市場の将来動向

第4章 ケタミン療法クリニック業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ケタミン療法クリニック市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 ケタミン療法クリニック市場情勢

  • ケタミン療法クリニック市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ケタミン療法クリニック市場- 治療別

  • 概要
    • 治療別のセグメントシェア分析
    • 不安
    • うつ病
    • PTSD
    • その他

第8章 ケタミン療法クリニック市場- 療法別

  • 概要
    • 療法別のセグメントシェア分析
    • オンライン療法
    • オンサイト療法

第9章 ケタミン療法クリニック市場- 紹介元別

  • 概要
    • 紹介元別のセグメントシェア分析
    • プライマリケア医
    • オンライン広告
    • メンタルヘルス専門家

第10章 ケタミン療法クリニック市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 米国
    • カナダ
  • 欧州
    • 概要
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ケタミン療法クリニック業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Arevipharma GmbH
    • Biotechnica Pharma Global（BPG）
    • NY Ketamine Infusions
    • Core One Labs
    • Johnson &Johnson
    • Pfizer
    • Field Trip Health and Wellness Ltd.
    • Save Minds
    • Ember
    • UQUIFA
    • Mindbloom
    • Ketamine Clinics
    • Vitalitas Denver Ketamine Clinic

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Ketamine Clinics Market: Treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Ketamine Clinics Market, by Treatment2018-2030 (USD Million)
  • TABLE Ketamine Clinics Market: Therapy Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy
  • TABLE Global Ketamine Clinics Market, by Therapy2018-2030 (USD Million)
  • TABLE Ketamine Clinics Market: Referral Source Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Referral Source
  • TABLE Global Ketamine Clinics Market, by Referral Source 2018-2030 (USD Million)
  • TABLE Ketamine Clinics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Ketamine Clinics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Europe Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE EuropeKetamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Europe Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)

List of Figures

  • FIGURE Ketamine Clinics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Treatment segment market share analysis, 2022&2030
  • FIGURE Treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapy segment market share analysis, 2022&2030
  • FIGURE Therapy segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Referral Source segment market share analysis, 2022&2030
  • FIGURE Referral Source segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Ketamine Clinics Market share and leading players, 2022
  • FIGURE Europe Ketamine Clinics Market share and leading players, 2022
  • FIGURE Asia Pacific Ketamine Clinics Market share and leading players, 2022
  • FIGURE Latin America Ketamine Clinics Market share and leading players, 2022
  • FIGURE Middle East and Africa Ketamine Clinics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Ketamine Clinics Market share analysis by country, 2022
  • FIGURE Germany Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Ketamine Clinics Market share analysis by country, 2022
  • FIGURE India Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Ketamine Clinics Market share analysis by country, 2022
  • FIGURE Brazil Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Ketamine Clinics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1484

REPORT HIGHLIGHT

Ketamine clinics market size was valued at USD 8,704.5 Million in 2022, expanding at a CAGR of 11.3% from 2023 to 2030.

Ketamine clinics are defined as hospitals that engage in therapeutic purposes by administering ketamine, a dissociative anesthetic, and analgesic drug. Moreover, as a potential treatment ketamine has drawn interest for numerous mental health conditions, especially anxiety disorders, post-traumatic stress disorder (PTSD), and treatment-resistant depression. In line with this, ketamine has shown promise in offering quick relief, generally within hours, while traditional antidepressant medications may require weeks or months to show results. Furthermore, ketamine clinics traditionally provide intravenous (IV) ketamine infusions or, in other cases, other forms of ketamine administration, including oral lozenges and nasal sprays.

Ketamine Clinics Market- Market Dynamics:

Research & Clinical Trials and Increasing Demand Ketamine will boost the market growth

The increasing prevalence of mental health conditions coupled with limitations of traditional treatments, in turn; there has been a rising demand for alternative therapies such as ketamine. Moreover, with the positive outcomes in early studies, more clinical trials and investigation is required to determine the long-term safety and effectiveness of ketamine for the treatment of mental health concern. In addition, as research develops the view and acceptance of ketamine as a treatment option may shift. Furthermore, some established medical practices and mental health clinics have started including ketamine treatment as part of their product line, as ketamine therapy gains more recognition. However, insurance coverage for ketamine therapy can be a major challenge, which may restrain the ketamine clinic's market growth over the forecast period.

Ketamine Clinics Market- Key Insights:

  • As per the analysis shared by our research analyst, the ketamine clinics market is estimated to grow annually at a CAGR of around 11.3% over the forecast period (2023-2030)
  • The ketamine clinics industry is projected to grow at a significant rate due to the rising prevalence of mental health conditions and limitations of traditional treatments
  • Based on therapy segmentation, on-site therapy was predicted to show maximum market share in the near future
  • Based on treatment segmentation, depression was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Ketamine Clinics Market- Segmentation Analysis:

The global ketamine clinics market is segmented on the basis of treatment, therapy, referral source, and region.

The market is divided into three categories based on treatment: anxiety, depression, PTSD, and others. The depression segment is likely to possess the largest revenue share owing to the growing number of adults with severe major depression. Additionally, in the medical community ketamine has gained attention for its potential use in treating depression. Moreover, ketamine clinics have emerged as specialized centers that provide ketamine therapy for patients who have suffered from depression or other mood disorders.

The market is divided into two categories based on therapy: online therapy and on-site therapy. The on-site therapy segment is likely to possess the market share over the forecast period. For mental health disorders increasing acceptance of ketamine therapy is led to an expansion of ketamine, further driving the segment growth. Additionally, mental health professionals also provide therapy sessions for patients including counselors, psychologists, and psychiatrists.

The market is divided into three categories based on referral sources: primary care physicians, online advertising, and mental health professionals. The primary care physicians segment is expected to dominate the market share. PCPs are suitable to diagnose and treat numerous medical conditions, such as mental health disorders like anxiety and depression. Moreover, primary care physicians may send their patients to ketamine clinics when primary care physicians think ketamine therapy might be helpful for severe or treatment-resistant depression or other mental health concerns. Thereby such factors may propel the segment growth.

Ketamine Clinics Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Ketamine Clinics Market- Competitive Landscape:

The market is witnessing significant growth, driven by factors including the ongoing opioid crisis, rising mental health awareness, and a large number of ketamine clinics across the globe. Moreover, ketamine clinics industries are focusing on numerous strategies such as partnerships, launching new services, mergers & acquisitions, and expansions to expand their market presence worldwide. Furthermore, as more providers have entered the space the ketamine clinics market has become more competitive. For instance, in April 2023, Mindbloom announced a partnership with SHIFT to provide at-home ketamine therapy as a benefit to its employees. Additionally, through this partnership, all SHIFT employees will have access to at-home ketamine therapy for a fraction of the normal price through Mindbloom.

Recent Developments:

For instance, in January 2022, Delic Holdings Corp announced its subsidiary, Ketamine Wellness Centers (KWC), has officially expanded operations into Utah with the opening of its Salt Lake City location.

Key features of the study:

  • This proposed research study on ketamine clinics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the ketamine clinics market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for ketamine clinics market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the ketamine clinics market.
  • Impact of COVID-19 on ketamine clinics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on ketamine clinics market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the ketamine clinics market, we have also included competitive landscape and key innovator analysis for the ketamine clinics market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the ketamine clinics market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global ketamine clinics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL KETAMINE CLINICS MARKET KEY PLAYERS

  • Arevipharma GmbH
  • Biotechnica Pharma Global (BPG)
  • NY Ketamine Infusions
  • Core One Labs
  • Johnson & Johnson
  • Pfizer
  • Field Trip Health and Wellness Ltd.
  • Save Minds
  • Ember
  • UQUIFA
  • Mindbloom
  • Ketamine Clinics
  • Vitalitas Denver Ketamine Clinic

GLOBAL KETAMINE CLINICS MARKET, BY TREATMENT

  • Anxiety
  • Depression
  • PTSD
  • Others

GLOBAL KETAMINE CLINICS MARKET, BY THERAPY

  • Online Therapy
  • On-Site Therapy

GLOBAL KETAMINE CLINICS MARKET, BY REFERRAL SOURCE

  • Primary Care Physicians
  • Online Advertising
  • Mental Health Professionals

GLOBAL KETAMINE CLINICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Ketamine Clinics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Ketamine Clinics Market Snippet by Treatment
    • 2.1.2. Ketamine Clinics Market Snippet by Therapy
    • 2.1.3. Ketamine Clinics Market Snippet by Referral Source
    • 2.1.4. Ketamine Clinics Market Snippet by Country
    • 2.1.5. Ketamine Clinics Market Snippet by Region
  • 2.2. Competitive Insights

3. Ketamine Clinics Key Market Trends

  • 3.1. Ketamine Clinics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Ketamine Clinics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Ketamine Clinics Market Opportunities
  • 3.4. Ketamine Clinics Market Future Trends

4. Ketamine Clinics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Ketamine Clinics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Ketamine Clinics Market Landscape

  • 6.1. Ketamine Clinics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Ketamine Clinics Market - By Treatment

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment, 2022&2030 (%)
    • 7.1.2. Anxiety
    • 7.1.3. Depression
    • 7.1.4. PTSD
    • 7.1.5. Others

8. Ketamine Clinics Market - By Therapy

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy, 2022&2030 (%)
    • 8.1.2. Online Therapy
    • 8.1.3. On-Site Therapy

9. Ketamine Clinics Market - By Referral Source

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Referral Source, 2022&2030 (%)
    • 9.1.2. Primary Care Physicians
    • 9.1.3. Online Advertising
    • 9.1.4. Mental Health Professionals

10. Ketamine Clinics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Ketamine Clinics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Ketamine Clinics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Ketamine Clinics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Ketamine Clinics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Ketamine Clinics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Ketamine Clinics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Arevipharma GmbH
    • 11.2.2. Biotechnica Pharma Global (BPG)
    • 11.2.3. NY Ketamine Infusions
    • 11.2.4. Core One Labs
    • 11.2.5. Johnson & Johnson
    • 11.2.6. Pfizer
    • 11.2.7. Field Trip Health and Wellness Ltd.
    • 11.2.8. Save Minds
    • 11.2.9. Ember
    • 11.2.10. UQUIFA
    • 11.2.11. Mindbloom
    • 11.2.12. Ketamine Clinics
    • 11.2.13. Vitalitas Denver Ketamine Clinic

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us